📰 Affinity Technologies News
Affinity Technologies News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Affinity Technologies. Real-time updates on events, politics, business and more.
May 7, 2024
BioAffinity Technologies (NASDAQ:BIAF – Get Free Report) is one of 39 publicly-traded companies in the “Commercial physical research” industry, but how does it weigh in compared to its competitors? We will compare bioAffinity Technologies to similar businesses based on the strength of its dividends, institutional ownership, earnings, risk, analyst recommendations, profitability and valuation. Earnings & […]
May 2, 2024
BioAffinity Technologies (NASDAQ:BIAF – Get Free Report) is one of 38 public companies in the “Commercial physical research” industry, but how does it weigh in compared to its competitors? We will compare bioAffinity Technologies to related companies based on the strength of its institutional ownership, earnings, analyst recommendations, risk, valuation, dividends and profitability. Analyst Recommendations […]
May 2, 2024
BioAffinity Technologies, Inc. shares recent Company news. CyPath® Lung Sales Ramp Up Month over Month Sales of CyPath® Lung, our noninvasive diagnostic test for the early detection of lung...
April 27, 2024
BioAffinity Technologies (NASDAQ:BIAF – Get Free Report) is one of 39 public companies in the “Commercial physical research” industry, but how does it weigh in compared to its rivals? We will compare bioAffinity Technologies to similar businesses based on the strength of its earnings, institutional ownership, valuation, analyst recommendations, dividends, profitability and risk. Institutional & […]
April 24, 2024
Collaboration with the US Department of Defense’s largest military health organization underway ...
April 24, 2024
BioAffinity Technologies (NASDAQ:BIAF – Get Free Report) is one of 39 publicly-traded companies in the “Commercial physical research” industry, but how does it compare to its competitors? We will compare bioAffinity Technologies to similar companies based on the strength of its institutional ownership, analyst recommendations, valuation, profitability, earnings, dividends and risk. Volatility and Risk bioAffinity […]
April 23, 2024
BioAffinity Technologies (NASDAQ:BIAF – Get Free Report) is one of 39 public companies in the “Commercial physical research” industry, but how does it weigh in compared to its competitors? We will compare bioAffinity Technologies to similar companies based on the strength of its institutional ownership, dividends, risk, profitability, analyst recommendations, valuation and earnings. Profitability This […]
April 22, 2024
BioAffinity Technologies (NASDAQ:BIAF – Get Free Report) is one of 39 publicly-traded companies in the “Commercial physical research” industry, but how does it compare to its competitors? We will compare bioAffinity Technologies to related companies based on the strength of its analyst recommendations, profitability, risk, earnings, dividends, valuation and institutional ownership. Insider and Institutional Ownership […]
April 22, 2024
BioAffinity Technologies (NASDAQ:BIAF – Get Free Report) is one of 39 publicly-traded companies in the “Commercial physical research” industry, but how does it compare to its rivals? We will compare bioAffinity Technologies to similar businesses based on the strength of its risk, valuation, institutional ownership, earnings, profitability, dividends and analyst recommendations. Analyst Ratings This is […]
April 20, 2024
BioAffinity Technologies (NASDAQ:BIAF – Get Free Report) is one of 39 public companies in the “Commercial physical research” industry, but how does it compare to its rivals? We will compare bioAffinity Technologies to similar companies based on the strength of its analyst recommendations, earnings, institutional ownership, valuation, risk, dividends and profitability. Analyst Ratings This is […]